Refractoriness of hepatitis C virus internal ribosome entry site to processing by Dicer in vivo

Journal of Negative Results in BioMedicine

Volumn 8, Issue 1, 2009, Pages

  Ouellet, Dominique L ^a,b   Plante, Isabelle ^a,b   Boissonneault, Vincent ^a,b   Ayari, Cherifa ^a,b   Provost, Patrick ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MICRORNA; RIBONUCLEASE III; RIBOSOME RNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; RIBOSOME; RNA INTERFERENCE; RNA PROCESSING; VIRUS ENTRY;

BASE SEQUENCE; CELL LINE; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE III; RIBOSOMES; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, RIBOSOMAL; RNA, VIRAL; SUBSTRATE SPECIFICITY; VIRUS INTERNALIZATION;

EID: 70349425846     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-8-8     Document Type: Article

References (67)

1. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. KE Reed CM Rice, Curr Top Microbiol Immunol 2000 242 55 84 10592656
2. Future therapy of hepatitis C. JG McHutchison K Patel, Hepatology 2002 36 5 Suppl 1 245 252 10.1002/hep.1840360731 12407600
3. Genetic organization and diversity of the hepatitis C virus. QL Choo KH Richman JH Han K Berger C Lee C Dong C Gallegos D Coit R Medina-Selby PJ Barr, et al. Proc Natl Acad Sci USA 1991 88 6 2451 2455 10.1073/pnas.88.6.2451 1848704
4. Expression and identification of hepatitis C virus polyprotein cleavage products. A Grakoui C Wychowski C Lin SM Feinstone CM Rice, J Virol 1993 67 3 1385 1395 7679746
5. Translation of hepatitis C virus RNA. CU Hellen TV Pestova, J Viral Hepat 1999 6 2 79 87 10.1046/j.1365-2893.1999.00150.x 10607219
6. Internal ribosome entry site-mediated translation in hepatitis C virus replication. RC Rijnbrand SM Lemon, Curr Top Microbiol Immunol 2000 242 85 116 10592657
7. Internal ribosome entry site within hepatitis C virus RNA. K Tsukiyama-Kohara N Iizuka M Kohara A Nomoto, J Virol 1992 66 3 1476 1483 1310759
8. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. C Wang P Sarnow A Siddiqui, J Virol 1993 67 6 3338 3344 8388503
9. Initiation of Protein Synthesis by Hepatitis C Virus Is Refractory to Reduced eIF2*GTP*Met-tRNAiMet Ternary Complex Availability. F Robert LD Kapp SN Khan MG Acker S Kolitz S Kazemi RJ Kaufman WC Merrick AE Koromilas JR Lorsch, et al. Mol Biol Cell 2006 17 11 4632 44 10.1091/mbc.E06-06-0478 16928960
10. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA. S Boni JP Lavergne S Boulant A Cahour, J Biol Chem 2005 280 18 17737 17748 10.1074/jbc.M501826200 15760888
11. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins. Y He W Yan C Coito Y Li M Gale Jr MG Katze, J Gen Virol 2003 84 Pt 3 535 543 10.1099/vir.0.18658-0 12604803
12. Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo. J Kato N Kato H Yoshida SK Ono-Nita Y Shiratori M Omata, J Med Virol 2002 66 2 187 199 10.1002/jmv.2129 11782927
13. Hepatitis C virus NS4A inhibits cap-dependent and the viral IRES-mediated translation through interacting with eukaryotic elongation factor 1A. YH Kou SM Chou YM Wang YT Chang SY Huang MY Jung YH Huang MR Chen MF Chang SC Chang, J Biomed Sci 2006 13 6 861 74 10.1007/s11373-006-9104-8 16927014
14. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein. T Shimoike C Koyama K Murakami R Suzuki Y Matsuura T Miyamura T Suzuki, Virology 2006 345 2 434 445 10.1016/j.virol.2005.10.013 16297950
15. A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. M Honda MR Beard LH Ping SM Lemon, J Virol 1999 73 2 1165 1174 9882318
16. Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. PJ Lukavsky GA Otto AM Lancaster P Sarnow JD Puglisi, Nat Struct Biol 2000 7 12 1105 1110 10.1038/81951 11101890
17. The nuclear RNase III Drosha initiates microRNA processing. Y Lee C Ahn J Han H Choi J Kim J Yim J Lee P Provost O Radmark S Kim, et al. Nature 2003 425 6956 415 419 10.1038/nature01957 14508493
18. Ribonuclease activity and RNA binding of recombinant human Dicer. P Provost D Dishart J Doucet D Frendewey B Samuelsson O Radmark, Embo J 2002 21 21 5864 5874 10.1093/emboj/cdf578 12411504
19. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. H Zhang FA Kolb V Brondani E Billy W Filipowicz, Embo J 2002 21 21 5875 5885 10.1093/emboj/cdf582 12411505
20. MicroRNAs: genomics, biogenesis, mechanism, and function. DP Bartel, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438
21. MicroRNAs in Gene Regulation: When the Smallest Governs It All. DL Ouellet MP Perron LA Gobeil P Plante P Provost, J Biomed Biotechnol 2006 2006 4 69616 17057368
22. A species of small antisense RNA in posttranscriptional gene silencing in plants. AJ Hamilton DC Baulcombe, Science 1999 286 5441 950 952 10.1126/science.286.5441.950 10542148
23. MicroRNAs in plants. BJ Reinhart EG Weinstein MW Rhoades B Bartel DP Bartel, Genes Dev 2002 16 13 1616 1626 10.1101/gad.1004402 12101121
24. Identification of virus-encoded microRNAs. S Pfeffer M Zavolan FA Grasser M Chien JJ Russo J Ju B John AJ Enright D Marks C Sander, et al. Science 2004 304 5671 734 736 10.1126/science.1096781 15118162
25. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. X Cai S Lu Z Zhang CM Gonzalez B Damania BR Cullen, Proc Natl Acad Sci USA 2005 102 15 5570 5575 10.1073/pnas.0408192102 15800047
26. Identification of microRNAs of the herpesvirus family. S Pfeffer A Sewer M Lagos-Quintana R Sheridan C Sander FA Grasser LF van Dyk CK Ho S Shuman M Chien, et al. Nat Methods 2005 2 4 269 276 10.1038/nmeth746 15782219
27. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Y Bennasser SY Le M Benkirane KT Jeang, Immunity 2005 22 5 607 619 10.1016/j.immuni.2005.03.010 15894278
28. HIV-1 nef suppression by virally encoded microRNA. S Omoto M Ito Y Tsutsumi Y Ichikawa H Okuyama EA Brisibe NK Saksena YR Fujii, Retrovirology 2004 1 1 44 10.1186/1742-4690-1-44 15601474
29. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. DL Ouellet I Plante P Landry C Barat ME Janelle L Flamand MJ Tremblay P Provost, Nucleic Acids Res 2008 36 7 2353 2365 10.1093/nar/gkn076 18299284
30. Double-stranded RNA binding may be a general plant RNA viral strategy to suppress RNA silencing. Z Merai Z Kerenyi S Kertesz M Magna L Lakatos D Silhavy, J Virol 2006 80 12 5747 5756 10.1128/JVI.01963-05 16731914 (Pubitemid 43849153)
31. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. WX Li H Li R Lu F Li M Dus P Atkinson EW Brydon KL Johnson A Garcia-Sastre LA Ball, et al. Proc Natl Acad Sci USA 2004 101 5 1350 1355 10.1073/pnas.0308308100 14745017
32. Induction and suppression of RNA silencing by an animal virus. H Li WX Li SW Ding, Science 2002 296 5571 1319 1321 10.1126/science.1070948 12016316
33. La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. SS Soldan ML Plassmeyer MK Matukonis F Gonzalez-Scarano, J Virol 2005 79 1 234 244 10.1128/JVI.79.1.234-244.2005 15596819
34. HCV core protein interacts with Dicer to antagonize RNA silencing. W Chen Z Zhang J Chen J Zhang Y Wu Y Huang X Cai A Huang, Virus Res 2008 133 2 250 258 10.1016/j.virusres.2008.01.011 18325616
35. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Y Wang N Kato A Jazag N Dharel M Otsuka H Taniguchi T Kawabe M Omata, Gastroenterology 2006 130 3 883 892 10.1053/j.gastro.2005.12.028 16530526
36. Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Ji A Glaser M Wernli JM Berke D Moradpour P Erb, J Gen Virol 2008 89 Pt 11 2761 2766 10.1099/vir.0.2008/002923-0 18931073
37. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. G Randall A Grakoui CM Rice, Proc Natl Acad Sci USA 2003 100 1 235 240 10.1073/pnas.0235524100 12518066
38. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. JA Wilson S Jayasena A Khvorova S Sabatinos IG Rodrigue-Gervais S Arya F Sarangi M Harris-Brandts S Beaulieu CD Richardson, Proc Natl Acad Sci USA 2003 100 5 2783 2788 10.1073/pnas.252758799 12594341
39. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. T Yokota N Sakamoto N Enomoto Y Tanabe M Miyagishi S Maekawa L Yi M Kurosaki K Taira M Watanabe, et al. EMBO Rep 2003 4 6 602 608 10.1038/sj.embor.embor840 12740604
40. Inhibition of hcv replication in HCV replicon by shRNAs. H Hamazaki H Takahashi K Shimotohno N Miyano-Kurosaki H Takaku, Nucleosides Nucleotides Nucleic Acids 2006 25 7 801 805 10.1080/15257770600726091 16898418
41. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. T Kanda R Steele R Ray RB Ray, J Virol 2007 81 2 669 676 10.1128/JVI.01496-06 17079316
42. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. CL Jopling M Yi AM Lancaster SM Lemon P Sarnow, Science 2005 309 5740 1577 1581 10.1126/science.1113329 16141076
43. MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse {beta}-Amyloid Precursor Protein-converting Enzyme 1. V Boissonneault I Plante S Rivest P Provost, J Biol Chem 2009 284 4 1971 1981 10.1074/jbc.M807530200 18986979
44. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. S Lu BR Cullen, J Virol 2004 78 23 12868 12876 10.1128/JVI.78.23.12868-12876.2004 15542639
45. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. M Frese T Pietschmann D Moradpour O Haller R Bartenschlager, J Gen Virol 2001 82 Pt 4 723 733 11257176
46. Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. R Prabhu V Joshi RF Garry F Bastian S Haque F Regenstein S Thung S Dash, Exp Mol Pathol 2004 76 3 242 252 10.1016/j.yexmp.2004.01.004 15126107
47. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Korner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 5424 110 113 10.1126/science.285.5424.110 10390360
48. HIV-l and the microRNA-guided silencing pathway: An intricate and multifaceted encounter. P Provost C Barat I Plante MJ Tremblay, Virus Res 2006 121 2 107 115 10.1016/j.virusres.2006.06.015 16889864
49. HIV-1 Tat interaction with Dicer: requirement for RNA. Y Bennasser KT Jeang, Retrovirology 2006 3 1 95 10.1186/1742-4690-3-95 17181864
50. Regulation of the hepatitis C virus genome replication by miR-199a. Y Murakami HH Aly A Tajima I Inoue K Shimotohno, J Hepatol 2008 50 3 453 60 10.1016/j.jhep.2008.06.010 19144437
51. Interferon modulation of cellular microRNAs as an antiviral mechanism. IM Pedersen G Cheng S Wieland S Volinia CM Croce FV Chisari M David, Nature 2007 449 7164 919 922 10.1038/nature06205 17943132 (Pubitemid 47598616)
52. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. JB Ma K Ye DJ Patel, Nature 2004 429 6989 318 322 10.1038/nature02519 15152257
53. Single processing center models for human Dicer and bacterial RNase III. H Zhang FA Kolb L Jaskiewicz E Westhof W Filipowicz, Cell 2004 118 1 57 68 10.1016/j.cell.2004.06.017 15242644
54. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. TP Chendrimada RI Gregory E Kumaraswamy J Norman N Cooch K Nishikura R Shiekhattar, Nature 2005 436 7051 740 744 10.1038/nature03868 15973356
55. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. E Maniataki Z Mourelatos, Genes Dev 2005 19 24 2979 2990 10.1101/gad.1384005 16357216
56. Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. N Ali A Siddiqui, J Virol 1995 69 10 6367 6375 7666538
57. Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by specific interaction of independent regions of human La autoantigen. R Pudi S Abhiman N Srinivasan S Das, J Biol Chem 2003 278 14 12231 12240 10.1074/jbc.M210287200 12540850
58. Interaction of poly(rC)-binding protein 2 with the 5'-terminal stem loop of the hepatitis C-virus genome. S Fukushi M Okada T Kageyama FB Hoshino K Nagai K Katayama, Virus Res 2001 73 1 67 79 10.1016/S0168-1702(00)00228-8 11163645
59. Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus. B Hahm YK Kim JH Kim TY Kim SK Jang, J Virol 1998 72 11 8782 8788 9765422
60. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. M Kruger C Beger PJ Welch JR Barber MP Manns F Wong-Staal, Mol Cell Biol 2001 21 24 8357 8364 10.1128/MCB.21.24.8357-8364.2001 11713272
61. Riboproteomics of the hepatitis C virus internal ribosomal entry site. H Lu W Li WS Noble D Payan DC Anderson, J Proteome Res 2004 3 5 949 957 10.1021/pr0499592 15473682
62. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. M Korf D Jarczak C Beger MP Manns M Kruger, J Hepatol 2005 43 2 225 234 10.1016/j.jhep.2005.02.046 15964661 (Pubitemid 40956874)
63. La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation. M Honda T Shimazaki S Kaneko, Gastroenterology 2005 128 2 449 462 10.1053/j.gastro.2004.11.064 15685555
64. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. B Wolk D Sansonno HG Krausslich F Dammacco CM Rice HE Blum D Moradpour, J Virol 2000 74 5 2293 2304 10.1128/JVI.74.5.2293-2304.2000 10666260
65. Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase. D Moradpour E Bieck T Hugle W Wels JZ Wu Z Hong HE Blum R Bartenschlager, J Biol Chem 2002 277 1 593 601 10.1074/jbc.M108748200 11641406
66. Dicer-Derived MicroRNAs Are Utilized by the Fragile X Mental Retardation Protein for Assembly on Target RNAs. I Plante L Davidovic DL Ouellet LA Gobeil S Tremblay EW Khandjian P Provost, J Biomed Biotechnol 2006 2006 4 64347 17057366
67. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. S Niranjanakumari E Lasda R Brazas MA Garcia-Blanco, Methods 2002 26 2 182 190 10.1016/S1046-2023(02)00021-X 12054895